Efficacy of oral terbinafine in feline dermatophytosis due to Microsporum canis

J Feline Med Surg. 1999 Mar;1(1):37-41. doi: 10.1016/S1098-612X(99)90008-6.

Abstract

Microsporum canis is the dermatophyte most commonly responsible for ringworm in cats. The purpose of this paper was to evaluate the in vivo efficacy of oral terbinafine (Lamisil; Sandoz) in the treatment of feline ringworm caused by M canis, and to consider this drug as an alternative to griseofulvin or imidazoles. Fifteen cats infected with M canis were treated orally once daily with 30 mg/kg of terbinafine over a 2-week period. All treated animals were checked for dermatophytes on the last day of treatment, a month later and 3 months after the last administration of the drug. Only 12 cats could be used in the whole trial and 11 of these (92%) showed a complete cure. Terbinafine could be an effective alternative to griseofulvin when fungal resistance or idiosyncrasic intolerance are shown and, compared with griseofulvin, could give a faster rate of cure and less relapses.

Publication types

  • Evaluation Study

MeSH terms

  • Administration, Oral
  • Animals
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use*
  • Cat Diseases / drug therapy*
  • Cats
  • Dermatomycoses / drug therapy
  • Dermatomycoses / veterinary*
  • Female
  • Griseofulvin / therapeutic use
  • Itraconazole / therapeutic use
  • Male
  • Microsporum
  • Naphthalenes / administration & dosage
  • Naphthalenes / therapeutic use*
  • Terbinafine
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Naphthalenes
  • Itraconazole
  • Griseofulvin
  • Terbinafine